Key points are not available for this paper at this time.
(1) Background: In vitro diagnostic (IVD) tests are the main means of obtaining diagnostic information for clinical purposes. The electrochemiluminescence immunoassay (ECLIA) has become an important in vitro diagnostic technique. It has unique advantages and broad market prospects due to its sensitivity, detection limit, detection range and reagent stability. At present, there is a need to develop and optimize electrochemiluminescence immunoassay subsystems to achieve high-throughput outputs and accurate detection of instruments to promote their clinical application. (2) Methods: On the basis of the demand for clinical testing instruments with high detection accuracy and speed, this study constructed an electrochemiluminescence immunoassay system by designing magnetic separation modules, introducing PMT and optimizing the system timing regulation capability. (3) Results: The magnetic separation modules can increase the detection accuracy, the PMT system increases the detection sensitivity and optimized system timing can achieve maximum test output. Furthermore, this system performs well in terms of its linearity, detection limit, signal-to-noise ratio, precision and accuracy. (4) Conclusions: The electrochemiluminescence immunoassay system is capable of high throughput with good sensitivity and accuracy, meeting the basic requirements of clinical applications for detection capacity and output throughput.
Building similarity graph...
Analyzing shared references across papers
Loading...
Xiancheng Liu
Shuang Zhao
Yan Xu
Bioengineering
Chongqing University
Chongqing Medical and Pharmaceutical College
Building similarity graph...
Analyzing shared references across papers
Loading...
Liu et al. (Sat,) studied this question.
www.synapsesocial.com/papers/68e5a17bb6db64358753bc5b — DOI: https://doi.org/10.3390/bioengineering11090885
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: